0001179110-19-000651.txt : 20190110
0001179110-19-000651.hdr.sgml : 20190110
20190110160633
ACCESSION NUMBER: 0001179110-19-000651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190108
FILED AS OF DATE: 20190110
DATE AS OF CHANGE: 20190110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vandervoort Adam C
CENTRAL INDEX KEY: 0001375088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 19520320
MAIL ADDRESS:
STREET 1: 485 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2019-01-08
0
0001477449
Teladoc Health, Inc.
TDOC
0001375088
Vandervoort Adam C
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
Chief Legal Officer, Secretary
Common Stock
2019-01-08
4
M
0
2734
8.71
A
2934
D
Common Stock
2019-01-08
4
M
0
456
9.60
A
3390
D
Common Stock
2019-01-08
4
M
0
913
12.21
A
4303
D
Common Stock
2019-01-08
4
M
0
1447
22.30
A
5750
D
Common Stock
2019-01-08
4
S
0
5500
53.80
D
200
D
Employee Stock Option (right to buy)
8.71
2019-01-08
4
M
0
2734
0.00
D
2025-02-25
Common Stock
2734
5468
D
Employee Stock Option (right to buy)
9.60
2019-01-08
4
M
0
456
0.00
D
2025-05-29
Common Stock
456
2278
D
Employee Stock Option (right to buy)
12.21
2019-01-08
4
M
0
913
0.00
D
2026-03-07
Common Stock
913
12790
D
Employee Stock Option (right to buy)
22.30
2019-01-08
4
M
0
1447
0.00
D
2027-03-03
Common Stock
1447
37615
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018.
The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
/s/ Adam C. Vandervoort
2019-01-10